Enrichment & Purging of Stem Cells in Non-Hodgkin's Lymphoma

Stanford University

Status: Completed

Conditions: Lymphoma, Non-Hodgkin

Treatments: Procedure: high dose chemo then auto hematopoietic cell transplant

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00186355

NCT00186355

BMT4IJ

12170 (Other Identifier)

77063 (Other Identifier)

Details and patient eligibility

About

To evaluate the role of purging the hematopoietic cell graft on outcomes for non-Hodgkin's Lymphoma.

Full description

To study the use of peripheral blood stem cells which have been treated in an effort to remove tumor cells. The researchers hope to learn whether or not this will be more effective in removing the tumor cells as compared to other methods of purging (the removal of cancer cells).

Enrollment: 97 patients

Sex: All

Ages: 4 weeks to 75 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:- relapsed NHL Exclusion Criteria:- liver dysfunction

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)